Defining the relationship between changes in specific features of CHIP and disease phenotypes may both reveal new clues to the spectrum of this disease and, ultimately, guide precision medicine-based strategies to treat SCAR16. This evidence concerns the gene STUB1 and autosomal recessive spinocerebellar ataxia 16.